Please wait ...

In the rapidly evolving field of infectious disease treatment, staying ahead requires more than just knowledge; it demands precision. Our advanced course is designed to equip healthcare professionals with cutting-edge strategies and insights for prescribing antimicrobial therapies.

As a clinician always striving to be the best, elevate your skills as an expert prescriber with confidence to:

  • Combat Antibiotic Resistance
  • Deal with Antibiotic Related Allergies Penicillin and Sulfa
  • Treat Skin and Soft Tissue Infections
  • Manage Respiratory Infections… Pneumonia, Influenza, RSV, TB, and more
  • Implement IDSA Recommendations for Clostridium Difficile Infection
  • Diagnose and Treat Hepatitis A, B, and C
  • Administer Vaccines for Adults and Kids
  • Prescribe Pediatric Medications for infections!
  • And More!

Take the next step in your professional journey and become a leader in infectious disease pharmacology. Enroll now and be at the forefront of precision prescribing!

Infectious Disease Pharmacology
Precision Strategies for Prescribing

Valued at $919.92
Yours Today for Only $505.96!
Earn up to 16.0 CE Hours INCLUDING up to 12.75 pharmacology CE hours!.
Click here for Credit details | Click here for course objectives and outline

Why Choose This Course?

  • Provides a deep dive into the pharmacological principles underlying antimicrobial therapy, with a focus on both common and emerging infectious diseases.
  • Learn from 5 leading experts in infectious disease pharmacology who bring real-world experience and the latest research directly to you.
  • Sharpen your decision-making skills so that you can apply what you learn in practice.
  • The latest guidelines, research findings, and treatment protocols.
  • Develop precision strategies for prescribing based on individual patient factors, microbial profiles, and resistance patterns.

Designed for advanced practice nurses, nurse practitioners, physician assistants, pharmacists, and all healthcare providers looking to deepen their expertise in infectious disease pharmacology.

Infectious Disease Pharmacology Course Outline
Eric Wombwell
Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians
Eric Wombwell, PharmD, BCIDP | Click here for information about Eric Wombwell
Includes up to 6.0 Pharmacology Hours

Covers evidence-based prescribing, patient education, and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases. Includes pharmacology of different classes of antimicrobials used to treat infectious disease states encountered in clinical practice, including new antimicrobials. Discover the spectrums of activity, pharmacokinetic characteristics, and parameters for monitoring therapeutic outcomes. You will finish this training better prepared to design appropriate and cost-effective drug regimens for improved therapeutic outcomes.

Considerations for Successful Empiric Therapy
  • Spectrum of activity for commonly used antibiotics
  • Normal flora for infectious sites
  • Resistance associated with common bacteria
  • Pharmacodynamic influences on antibiotic dosing

Interpretation of Microbiologic Test Results
  • Gram stain results
  • Culture and sensitivity results
  • Minimum inhibitory concentration (MIC) evaluation
  • PCR results

Antibacterial Resistance
  • Trends
  • Mechanisms of resistance
  • Contributing factors
  • Antibiotic stewardship concepts

Antibiotic Related Allergies Penicillin and 'Sulfa'
  • Define true allergy versus side effect
  • Penicillin allergy and cephalosporin cross sensitivity
  • 'Sulfa' allergy

Skin and Soft Tissue Infections
  • Streptococcus pyogenes vs. MRSA
  • Review evidence for antibiotic management
  • Review IDSA treatment guidelines
  • Vancomycin AUC/MIC monitoring
Pneumonia
  • Review evidence for pathogen etiology
  • Review evidence for antibiotic management
  • IDSA/ATS community-acquired pneumonia treatment guidelines
  • Resistance risk factors and management
  • Review new antibiotics for MDR infections

Influenza
  • Review evidence for vaccine timing and use in older adults
  • Review of clinical trial data for therapeutics
  • Review IDSA/CDC treatment guidelines

Urinary Tract Infections
  • Review evidence for resistance trends
  • Review of clinical trial data for therapeutics
  • Antibiotics for MDR infections

Clostridium Difficile Infection
  • Risk factor evidence review
  • Compare antibiotic risk levels
  • Review IDSA treatment guidelines
  • Review of clinical trial data for therapeutics
  • Probiotics prophylaxis evidence review

Eric Wombwell, PharmD, BCIDP, is a board-certified infectious diseases pharmacist and clinical associate professor for the Department of Pharmacy Practice and Administration at the University of Missouri — Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP-accredited pharmacy practice residency at the Kansas City VA Medical Center. Following residency, he accepted a full-time non-tenured clinical faculty position at the University of Missouri — Kansas City, School of Pharmacy. His teaching responsibilities include infectious diseases topics throughout the curriculum. Eric also has a clinical appointment at Centerpoint Medical Center rounding with the infectious diseases consult team and supporting antimicrobial stewardship efforts at the facility. Eric is regularly published in pharmacy and infectious diseases research and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the "Missouri Pharmacist Association — UMKC Faculty Member of the Year", and the “University of Missouri — Kansas City Provost's Award for Excellence in Teaching”.


Audrey M. Stevenson
Vaccine-Preventable Diseases in the Older Adults
Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC | Click here for information about Audrey M. Stevenson
Includes up to 0.5 Pharmacology Hours

Includes the most common vaccine-preventable diseases in older adults, including transmission, clinical presentation, diagnosis, treatment, and prevention. Provides an update on the most current vaccine recommendations and therapies to care for older adults.

Burden of Vaccine-Preventable Diseases in the Older Adult
  • Why disease is worse in the older adult
  • Herd immunity
  • The immune response of the older adult
  • Economics of diseases

Influenza
Transmission
  • Impact of the disease in the older adult (Hospitalizations, deaths)
  • Diagnostics
  • Treatment
  • Vaccine recommendations

COVID-19
Still with us!
  • Why it is more severe in certain individuals (risk factors)
  • Transmission (what we have learned)
  • Diagnosis
  • Current treatments
  • Vaccine recommendations
  • What's on the Horizon

RSV
Not just a childhood disease
  • Extent of the disease burden in older adults
  • Clinical symptoms
  • Diagnosis
  • Treatment
  • Newest vaccines available

Pertussis
How are we doing in controlling this
  • Extent of the disease in older adults
  • Vaccine levels in the U.S.
  • Diagnosis
  • Treatment
  • Vaccine recommendations
Shingles
Extent of the disease in older adults
  • Clinical signs and symptoms
  • Diagnosis
  • Treatment
  • Vaccine recommendations

Pneumococcal
What is it and how does it affect older adults
  • How is it transmitted
  • Complications associated with it
  • Clinical presentations
  • Diagnosis
  • Treatment
  • Vaccine recommendations

Hepatitis
  • Which types are a concern for older adults and which populations?
  • Transmission by type
  • Presentation of each type
  • Diagnosis
  • Treatment
  • Vaccine recommendations

Special populations
Vaccines for special populations (Diabetes, traveler, missing vaccines)

What's on the Horizon
Combination vaccines
  • Universal flu
  • Diseases with vaccines under development
Wrapping Up
What can the NP/PA do to improve vaccine levels?
  • Why your recommendation matters
  • Having difficult conversations

Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC, is a family nurse practitioner with more than 40 years of clinical and public health, and leadership experience. Dr. Stevenson, who holds a Master of Public Health and Master of Nursing degrees, received her doctorate in public health from the University of Utah. She has worked in public health for the past 34 years and is the former Division Director of Family Health and Clinical Services of the Salt Lake County Health Department in Salt Lake City, Utah. She is currently working in clinical research and teaching graduate FNP and MPH students at two universities. Dr. Stevenson has worked in various inpatient and ambulatory settings and was a previous nurse consultant to the Salt Lake City School District. She is a current faculty member of a graduate Nurse Practitioner program and a Master of Public Health program. She has published several articles and has been a national and international speaker on topics affecting school nurses, advanced practice nurses, and other medical and pharmacy providers. Dr. Stevenson is also a member of the statewide vaccine advisory board, where she collaborates on vaccine policies and recommendations for the state. Previously, Dr. Stevenson served as Vaccination Branch Director for the Covid-19 Incident Command for Salt Lake County.


Paul Langlois
Emerging and Current Infectious Diseases in the Critical Care Setting: SARs-CoV/COVID-19, Monkey Pox, Hepatitis, Tuberculosis & Influenza
Paul Langlois, APN, PhD, CCRN, CCNS | Click here for information about Paul Langlois

Since the beginning of the 21st century, we have seen novel infectious diseases and infectious diseases not endemic to the US manifest themselves in an explosive way. The daily news programs and the internet are providing sometimes overwhelming information that is often inadequate in scope. In this session, Paul Langlois, APN, PhD, CCRN, CCNS, will provide the latest guidelines and recommendations from the Centers for Disease Control (CDC) and Infectious Disease Society of America (IDSA) on current infectious diseases affecting our patients: SARS-CoV2/COVID-19; Monkeypox; hepatitis A, B, and C; tuberculosis and Influenza. In addition to history and physical assessment findings, Paul will also highlight recognition methods, FDA-approved and investigational medications, and, where indicated, vaccines. Case studies will solidify learning objectives.

SARS-CoV2/COVID-19 Updates
  • Pathophysiology of SARS-CoV2/COVID-19
  • Why so many variants?
  • Laboratory parameters for SARS-CoV2
  • Effectiveness of all the COVID-19 vaccines
  • Antiviral medications: FDA approved vs. those in clinical trials
  • Long-COVID-19 signs and symptoms

Monkeypox
  • Where did it originate?
  • Diagnostics
  • Prevalence in the USA
  • Infection control measures
  • Medications: FDA approved and investigational
  • Vaccine priorities
Hepatitis A, B, and C
  • Prevalence is rising in the USA
  • Patient history and presenting signs and symptoms
  • Diagnostic tests
  • Treatments and vaccines

Tuberculosis (TB): Still prevalent and highly contagious
  • What is Mycobacterium tuberculosis and how is it detected?
  • Newly diagnosed- and multi-drug resistant-TB in these geographic areas
  • First line medications for drug susceptible TB (doses, how often and how long to take)
  • Multi-drug resistant TB treatments

Influenza
  • Differentiating influenza from other conditions
  • Prophylactic medications
  • Antiviral treatments
  • Why do we need an annual influenza vaccine?
  • Combination COVID and influenza vaccine

Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU, and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists, and physicians. Dr. Langlois' presentations are evidence-based and timely, and provide participants with numerous case studies to facilitate critical thinking.


Christa A. Schorr
Sepsis and Septic Shock
Christa A. Schorr, DNP, MSN, RN, NEA-BC | Click here for information about Christa A. Schorr
Includes up to 6.0 Pharmacology Hours

Sepsis is a life-threatening condition and continues to have a high morbidity and mortality. Developing an understanding of early sepsis recognition and applying the appropriate treatment in a timely manner can help save lives. Nurses are essential in early recognition and early treatment. The most current 2021 Surviving Sepsis Campaign (SSC) Guidelines are useful in providing recommendations and rationale for treatment. Also new to the 2021 guidelines is a section on long-term outcomes and goals of care. As more and more individuals survive sepsis, resources to aid in their recovery are needed to improve long-term outcomes. This talk is relevant for individuals who care for patients with sepsis and septic shock and is a core measure for the Centers of Medicare and Medicaid. Nurses can make a difference in the lives of patients with sepsis and in the process improve compliance with the performance measure as well.

Sepsis Background Physiology
  • Why Sepsis, Why Now?
  • Sepsis Facts
  • Stakeholders

Sepsis Definitions
  • Systemic Inflammatory Response Syndrome (SIRS)
  • Sepsis
  • Severe Sepsis
  • Septic Shock

Assessment Criteria
  • Sequential [Sepsis-related] Organ Failure Assessment Score (Sofa)
  • Most recent SSC guidelines -Sepsis Bundle Project (SEP)
  • National Hospital Inpatient Quality Measures
  • SEP-1 Early Management Bundle, Severe Sepsis/Septic Shock
Implications for nursing practice
  • Mortality based on organ failures
  • Sepsis Bundles
  • Early Patient Identification
  • Screening Tools
  • Early Treatment in ICU

Long-term outcomes for survivors of sepsis
  • Educate and Empower Patients & Family
  • Goals of Care
  • SCC Recommendations
  • Shared Decision- Making Sepsis Survivors
  • Return to Normal
    • Psychological Support
    • Physical Support
    • Family Support
    • Cognitive Impairment
    • Self-Perception

Christa A. Schorr, DNP, MSN, RN, NEA-BC, is a clinical nurse scientist at Cooper University Health Care and Professor of Medicine at Cooper Medical School of Rowan University. Dr. Schorr has more than 25 years of clinical, quality improvement, and research experience in critical care. She has authored or co-authored more than 200 peer-reviewed articles, invited book chapters, and abstracts. Dr. Schorr was the group head for the 2021 Surviving Sepsis Campaign Guidelines Long-Term Outcomes and Goals of Care Section. In 2021, she was the recipient of the prestigious Asmund S. Laerdal Memorial Award in conjunction with the 50th Annual Society of Critical Care Medicine Congress — Recognition for research and publications.

Infectious Disease Pharmacology
Precision Strategies for Prescribing

Valued at $919.92
Yours Today for Only $505.96!
Earn up to 16.0 CE Hours INCLUDING up to 12.75 pharmacology CE hours!.
Click here for Credit details | Click here for course objectives and outline
PEDIATRIC BONUS TOPICS!
Register Today to Receive FOUR FREE Bonus Modules on Pediatric Pharmacology
(YES! Get FREE CE Hours, including pharmacology hours!)
Teri Woo
Pediatric Immunization Update
Teri Woo, PhD, ARNP, CPNP-PC, CNL, FAANP | Click here for information about Eric Wombwell
Includes up to 1.0 Pharmacology Hour

The vaccine recommendations keep changing, with new vaccines and new combinations available. Learn about the latest CDC and ACIP recommendations for vaccines, travel recommendations, and working with families to overcome vaccine hesitancy. Be ready to teach your patients and families and protect the kids you care for!

Vaccine statistics
  • Worldwide
  • US

Current CDC and ACIP recommendations for pediatric and adolescent recommendations
  • New vaccines
  • Updated recommendations for existing vaccines
  • Catch up schedules
  • Vaccinating for medical conditions
Travel recommendations
  • Resources for travel vaccine information
  • Measles vaccine before travel
  • Hepatitis A vaccine before travel
  • Polio booster before travel to high risk areas

Vaccine adverse event reporting (VAERS)

Overcoming vaccine hesitancy

Vaccines on the horizon


Pediatric Antibiotic Prescribing 101
Teri Woo, PhD, ARNP, CPNP-PC, CNL, FAANP | Click here for information about Eric Wombwell
Includes up to 1.0 Pharmacology Hour

With increasing antimicrobial resistance, our role as judicious prescribers of antibiotics is key. In this session, antibiotic pharmacology, antibiograms, and inappropriate antibiotic prescribing will be discussed. Recommendations for penicillin allergy will also be covered.

Antimicrobial resistance in the US and worldwide
  • Trends in antibiotic resistance
  • Over-use of antibiotics leading to resistance
  • Emergence of resistant fungal infections
  • How antimicrobial resistance evolves
  • Review of sensitivity

Review of antibiotic pharmacology
  • Antibiotic classes
  • Antibiotic pharmacodynamics
Use of antibiogram
  • Antibiotic choices based on pathogen susceptibility
  • Understanding local resistance patterns

Managing penicillin allergy
  • Accurate diagnosis of penicillin allergy
  • Penicillin allergy testing

Inappropriate antibiotic prescribing
  • Statistics
  • Impact of inappropriate antibiotic prescribing

Pediatric Antibiotic Prescribing 201
Teri Woo, PhD, ARNP, CPNP-PC, CNL, FAANP | Click here for information about Eric Wombwell
Includes up to 1.0 Pharmacology Hour

Do you know how to prescribe the right drug for the right bug? Learn how to select the correct antibiotic to prescribe for the treatment of respiratory, skin, urinary, and eye infections. We even cover antibiotic treatment for gonorrhea and chlamydia. Feel confident to order the right antibiotic every time.

Treating common pediatric respiratory infections
  • Otitis media
  • URI vs sinus infections
  • Pneumonia
  • Group A strep

Treating common skin infections
  • Impetigo
  • Cellulitis/boils
  • Paronychia
  • Animal bites
  • Treating urinary tract infections
  • Infants and children under age 2 years
  • Young children
  • Adolescents

Treating eye infections

Treating gonorrhea and chlamydia

Preventing and Treating Viral Infections in Children
Teri Woo, PhD, ARNP, CPNP-PC, CNL, FAANP | Click here for information about Eric Wombwell
Includes up to 1.25 Pharmacology Hours

Understanding the intracellular life cycle of viral pathogens and reviewing immunizations that prevent or mitigate common viral infections…such as influenza, herpes, varicella, and Hep C is key to treatment! Learn the latest strategies to safeguard children and master cutting-edge treatments.

Intracellular life cycle of viral pathogens

Common viral infections treated in children

Immunizations to prevent viral infections
  • Polio
  • MMR
  • Varicella
  • Rotavirus
  • Influenza
  • Hepatitis A
  • Hepatitis B
  • Human papillomavirus
  • COVID-19
  • Ebola
  • Mpox
Prescribing antiviral medications to children
  • Antivirals for influenza
  • Antivirals for herpes
  • Antivirals for varicella
  • PrEP
  • Antivirals for Hepatitis C

Prescribing immune globulins for children

Hear what your colleagues are saying about the Infectious Disease Pharmacology Course


Frequently Asked Questions about the Infectious Disease Pharmacology Course

This Infectious Disease Pharmacology Course is what you want to get to the next level and keep in your toolbox throughout your career. This self-study course provides superior training and knowledge in prescribing and managing pediatric medications. It includes diagnostic testing, medication updates, and prescription strategies… for bacterial infections, immunizations, viral illnesses, conditions, and more to provide updates and optimal patient outcome achievement strategies.

This course may be right for you if you are a pharmacology nurse, nurse practitioner, clinical nurse specialist, physician assistant, physician, pharmacist nurse, or anyone else who provides care to adults and children. Click here for Credit details.

With over 16 hours of online video training, insightful commentary, interventions, and examples, you will have compelling new clinical strategies that you can immediately start applying in your practice! We encourage you to take the time to fully absorb everything. Watch the videos. Read the materials. Get your CE hours!

But, if you review all of the course materials and are still not satisfied, call us at 800-844-8260. Your satisfaction is guaranteed.

No prior experience is necessary. Our expert trainers will give you the tools you need to create safety and trust, decrease self-harm, and inspire positive change.

Yes! Once you register for this self-directed course, the materials are yours to keep, access, and review for as long as you have your account.

Yes, you can use your PESI CE hours for your recertification as a PNP, FNP, AGFNP, PA, and more. Check with your certifying board for additional information.

Absolutely, this Infectious Disease Pharmacology Course is meant for anyone who prescribes or manages medications, in any setting. It covers medication management and prescribing strategies for all patients, which likely includes many of the patients you see as an FNP!
Infectious Disease Pharmacology
Precision Strategies for Prescribing

Valued at $919.92
Yours Today for Only $505.96!
Earn up to 16.0 CE Hours INCLUDING up to 12.75 pharmacology CE hours!.
Click here for Credit details | Click here for course objectives and outline
100% Satisfaction Guarantee
Register for this intensive training course without risk. If you're not completely satisfied, give us a call at 800-844-8260.

We’re that confident you'll find this learning experience to be all that's promised and more than you expected.

NOTE: No additional discounts or coupons may be applied to this course.
CRS002048 • © PESI Inc. • All rights reserved • Email: courses@pesi.com • Phone: 800-844-8260
Back to Top